Stock EMMLD OKYO PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart OKYO Pharma Limited

Equities

EMMLD

GG00BMFG5F62

Market Closed - Nasdaq
Other stock markets
 21:30:00 25/06/2024 BST 		5-day change 1st Jan Change
1.16 USD -4.13% Intraday chart for OKYO Pharma Limited -9.38% -34.46%
03-22 H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating MT
03-22 OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
OKYO PHARMA LIMITED
Biopharmaceuticals
-4.13%-9.38%-34.46%-5.69%+62.24% 40.22M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. EMMLD Stock
  4. Charts OKYO Pharma Limited
  5. Comparison Chart